Bill Text: NY S05553 | 2015-2016 | General Assembly | Amended


Bill Title: Directs the health care quality and cost containment commission to study and report upon the impact of requiring that certain health insurance plans provide coverage for treatment of mitochondrial disease.

Spectrum: Partisan Bill (Republican 2-0)

Status: (Introduced - Dead) 2016-06-07 - PRINT NUMBER 5553B [S05553 Detail]

Download: New_York-2015-S05553-Amended.html


                STATE OF NEW YORK
        ________________________________________________________________________
                                         5553--B
                               2015-2016 Regular Sessions
                    IN SENATE
                                      May 14, 2015
                                       ___________
        Introduced  by  Sen.  LITTLE -- read twice and ordered printed, and when
          printed to be committed to the Committee on Health --  recommitted  to
          the  Committee  on  Health in accordance with Senate Rule 6, sec. 8 --
          committee discharged, bill amended, ordered reprinted as  amended  and
          recommitted  to said committee -- reported favorably from said commit-
          tee  and  committed  to  the  Committee  on  Insurance  --   committee
          discharged, bill amended, ordered reprinted as amended and recommitted
          to said committee
        AN ACT to amend the insurance law, in relation to directing the New York
          state health care quality and cost containment commission to study and
          report  upon  the  impact  of  requiring that certain health insurance
          plans provide coverage for treatment of mitochondrial disease
          The People of the State of New York, represented in Senate and  Assem-
        bly, do enact as follows:
     1    Section 1. Section 213 of the insurance law is amended by adding a new
     2  subdivision (e) to read as follows:
     3    (e)  The  commission shall cause a study to be performed on the impact
     4  of requiring certain health insurance  plans  to  provide  coverage  for
     5  treatment  of mitochondrial disease. Such study shall include an assess-
     6  ment of the impact of such a requirement on costs to providers, the cost
     7  of insurance premiums, and the fiscal impact to the state.  The  commis-
     8  sion  shall submit a report of the findings, conclusions and recommenda-
     9  tion of such study, on or before November thirtieth, two thousand seven-
    10  teen, to the governor,  the  temporary  president  of  the  senate,  the
    11  speaker of the assembly, the chairs of the senate and assembly insurance
    12  committees, and the chairs of the senate and assembly health committees.
    13    § 2. This act shall take effect immediately.
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.
                                                                   LBD11057-05-6
feedback